Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells

Shigeru Kawabata(National Cancer Institute), Phillip A. Dennis(National Cancer Institute)
Cell Death and Disease
July 19, 2012
Cited by 72


Related Papers